Prostate cancer, Prostate-specific antigen, Surgery, Prostate and Prostatectomy are his primary areas of study. His studies deal with areas such as Gynecology, Radiation therapy and Urology as well as Prostate cancer. His study on Prostate-specific antigen also encompasses disciplines like
His study in Surgery is interdisciplinary in nature, drawing from both Neoadjuvant therapy and Epidemiology. His research in Prostate tackles topics such as Proportional hazards model which are related to areas like Cause of death. Within one scientific family, he focuses on topics pertaining to Cohort study under Prostatectomy, and may sometimes address concerns connected to Cohort.
Anthony V. D'Amico mostly deals with Prostate cancer, Internal medicine, Oncology, Prostate and Urology. His Prostate cancer research includes themes of Radiation therapy, Surgery and Gynecology. His Oncology research incorporates themes from MEDLINE, Randomized controlled trial, PCA3, Disease and Comorbidity.
His work carried out in the field of Prostate brings together such families of science as Nuclear medicine, Pathology, Magnetic resonance imaging, Proportional hazards model and Adenocarcinoma. His Urology research incorporates elements of Biopsy and PSA Velocity. His Prostatectomy research is multidisciplinary, relying on both Stage and Odds ratio.
Anthony V. D'Amico spends much of his time researching Prostate cancer, Internal medicine, Oncology, Radiation therapy and Androgen deprivation therapy. His Prostate cancer study combines topics in areas such as Prostate, Brachytherapy and Hazard ratio. As part of his studies on Internal medicine, Anthony V. D'Amico often connects relevant subjects like Gynecology.
His work deals with themes such as PSA Failure, MEDLINE, Randomized controlled trial, Risk of death and Disease, which intersect with Oncology. Anthony V. D'Amico interconnects Guideline and Androgen in the investigation of issues within Radiation therapy. His studies in Prostatectomy integrate themes in fields like Odds ratio, Adjuvant, Biopsy and Surgery.
His scientific interests lie mostly in Prostate cancer, Internal medicine, Oncology, Radiation therapy and Hazard ratio. His research integrates issues of Prostate and Brachytherapy in his study of Prostate cancer. The concepts of his Prostate study are interwoven with issues in Interquartile range and Urology.
Anthony V. D'Amico usually deals with Internal medicine and limits it to topics linked to Gynecology and Comorbidity and PSA Failure. The Oncology study combines topics in areas such as Odds ratio, Randomized controlled trial, MEDLINE and Watchful waiting. He has included themes like Medical literature and Medical physics in his Radiation therapy study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Gene expression correlates of clinical prostate cancer behavior.
Dinesh Singh;Phillip G. Febbo;Phillip G. Febbo;Kenneth Ross;Donald G. Jackson.
Cancer Cell (2002)
Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update
Ian Thompson;James Brantley Thrasher;Gunnar Aus;Arthur L. Burnett.
The Journal of Urology (2007)
Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer
A.V. D'Amico;R. Whittington;S.B. Malkowicz;D. Schultz.
The Journal of Urology (1999)
Prostate cancer. Clinical practice guidelines in oncology.
James Mohler;Robert R. Bahnson;Barry Boston;J. Erik Busby.
Journal of The National Comprehensive Cancer Network (2010)
American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010
Andrew M.D. Wolf;Richard C. Wender;Ruth B. Etzioni;Ian M. Thompson.
CA: A Cancer Journal for Clinicians (2010)
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
James L. Mohler;Emmanuel S. Antonarakis;Andrew J. Armstrong;Anthony V. D'Amico.
Journal of The National Comprehensive Cancer Network (2019)
Preoperative PSA Velocity and the Risk of Death from Prostate Cancer after Radical Prostatectomy
Anthony V. D'Amico;Ming Hui Chen;Kimberly A. Roehl;William J. Catalona.
The New England Journal of Medicine (2004)
6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial.
Anthony V. D'Amico;Judith Manola;Marian Loffredo;Andrew A. Renshaw.
JAMA (2004)
Comparative effectiveness of minimally invasive vs open radical prostatectomy.
Jim C. Hu;Xiangmei Gu;Stuart R. Lipsitz;Michael J. Barry.
JAMA (2009)
Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial.
Anthony V. D’Amico;Ming-Hui Chen;Andrew A. Renshaw;Marian Loffredo.
JAMA (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Connecticut
Harvard Medical School
Memorial Sloan Kettering Cancer Center
Brigham and Women's Hospital
Brigham and Women's Hospital
University at Buffalo, State University of New York
University of California, San Francisco
University of Pennsylvania
Harvard University
Duke University
Leiden University
Victoria University of Wellington
Brigham Young University
IBM (United States)
Boston University
Polytechnic University of Milan
University of Jinan
Xiamen University
University of the Basque Country
Westlake University
Nagoya University
University of Helsinki
Florey Institute of Neuroscience and Mental Health
Tufts University
Norwegian University of Science and Technology
Northeastern University